Package Insert: Information for the User
Omeprazole STADA 20 mg Hard Gastroresistant Capsules EFG
Read this package insert carefully before starting to take this medicine, as it contains important information for you.
-Keep this package insert, as you may need to read it again.
-If you have any questions, consult your doctor or pharmacist.
-This medicine has been prescribed only for you and should not be given to others, even if they have the same symptoms as you, as it may harm them.
-If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package insert. See section 4.
Omeprazol STADA contains the active ingredient omeprazole. It belongs to a group of medicines called “proton pump inhibitors”. These medicines work by reducing the amount of acid produced by the stomach.
Omeprazol STADA is used to treat the following diseases:
In adults:
In children:
Children over 1 year of age and ≥ 10 kg
Children over 4 years of age and adolescents
Do not take Omeprazol STADA
If you are unsure, talk to your doctor or pharmacist before taking Omeprazol STADA.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Omeprazol STADA.
Omeprazol STADA may mask the symptoms of other diseases. Therefore, if you experience any of the following symptoms before starting to take Omeprazol STADA or during treatment, consult your doctor immediately if:
If you have a skin rash, especially in sun-exposed areas, consult your doctor as soon as possible, as it may be necessary to interrupt treatment with Omeprazol STADA. Remember to mention any other symptoms you may notice, such as joint pain.
If you take Omeprazol STADA for a long period (more than 1 year), your doctor will likely perform regular check-ups. You should inform your doctor of any new or unusual symptoms and circumstances whenever you visit.
If you are taking proton pump inhibitors such as Omeprazol STADA, especially for more than a year, you may have a slightly increased risk of fractures of the hip, wrist, and spine. Inform your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).
Omeprazole may interfere with some tests (Cromogranina A). To avoid this interference, treatment with omeprazole should be temporarily suspended at least 5 days before the test.
When taking omeprazole, inflammation of the kidneys may occur. Symptoms and signs may include decreased urine volume or blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. You should inform your doctor of these signs.
Use of Omeprazol STADA with other medicines
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medicine, including those purchased without a prescription. Omeprazol STADA may affect the mechanism of action of some medicines, and some medicines may affect Omeprazol STADA.
Do not take Omeprazol STADA if you are taking a medicine that containsnelfinavir(used to treat HIV infection).
Inform your doctor or pharmacist if you are taking any of the following medicines:
If your doctor has prescribed you antibiotics amoxicillin and clarithromycin to treat ulcers caused by Helicobacter pylori infection, it is very important to inform your doctor of any other medicines you are taking.
Taking Omeprazol STADA with food and drinks
See section 3.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Omeprazole passes into breast milk but is unlikely to affect the baby when used in therapeutic doses. Your doctor will decide if you can take Omeprazol STADA if you are breastfeeding.
Driving and operating machinery
Omeprazol STADA is unlikely to affect your ability to drive or use tools or machines. However, side effects such as dizziness and visual disturbances (see section 4) may occur. If they do, you should not drive or use machines.
Omeprazol STADA contains saccharose
This medicine contains saccharose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
Omeprazol STADA contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per capsule; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Your doctor will tell you how many capsules to take and for how long. This will depend on your condition and age.
The usual doses are indicated below.
Adults:
Treatment of symptoms of GERD, such asheartburn and acid regurgitation:
Treatment ofulcers in the upper part of the intestine(duodenal ulcer):
Treatment ofstomach ulcers(gastric ulcer):
Preventionof the recurrence ofstomach and duodenal ulcers:
Treatment of stomach and duodenal ulcers caused by(nonsteroidal anti-inflammatory drugs):
Prevention of stomach and duodenal ulcersduring the administration ofNSAIDs:
Treatment of ulcers caused by Helicobacter pylori infection and prevention of their recurrence:
Treatment of excess acid in the stomach caused by atumor in the pancreas (Zollinger-Ellison syndrome):
Use in children and adolescents
Treatment of symptoms of GERD, such asheartburn and acid regurgitation
Treatment ofulcers causedby the infectionby Helicobacter pyloriand prevention of their recurrence:
How to take this medication
What to do if you or your child have trouble swallowing the capsules
-Open the capsules and swallow the contents directly with half a glass of water or pour the contents into a glass of water without gas, a sour fruit juice (e.g., apple, orange, or pineapple) or apple sauce.
-Always shake the mixture just before drinking it (the mixture will not be transparent). Then, drink the mixture immediately or within 30 minutes.
-To ensure that all the medication has been taken, fill the glass of water to half, rinse it well, and drink the water. The solid parts contain the medication; do not chew or crush them.
What to do if you take more Omeprazol STADA than you should
If you have taken more Omeprazol STADA than prescribed by your doctor, consult your doctor or pharmacist immediately. You can also call the Toxicological Information Service, phone: (91) 562 04 20, indicating the medication and the amount taken.
What to do if you forget to take Omeprazol STADA
If you forget to take a dose, take it as soon as you remember. However, if there is little time left for the next dose, skip the missed dose. Do not take a double dose to compensate for the missed doses. If you have any other questions about the use of this medication, ask your doctor or pharmacist.
What to do if you interrupt the treatment with Omeprazol STADA
Do not interrupt the treatment with Omeprazol STADA without first talking to your doctor or pharmacist.
Like all medications, this medication may cause side effects, although not everyone will experience them.
If you experience any of the following rare but serious side effects, stop taking Omeprazol STADA and consult your doctor immediately:
Other side effects are:
Frequent side effects(may affect up to 1 in 10 people)
Infrequent side effects(may affect up to 1 in 100 people)
Rare side effects(may affect up to 1 in 1,000 people)
Very rare side effects(may affect up to 1 in 10,000 people)
Unknown frequency(cannot be estimated from available data)
In very rare cases, Omeprazol STADA may affect white blood cells in the blood and cause immunodeficiency. If you experience an infection with symptoms such as high fever and a severely deteriorated general condition or fever with local infection symptoms, such as neck pain, throat pain, or mouth pain or difficulty urinating, you should consult your doctor as soon as possible to perform a blood test and rule out a lack of white blood cells (agranulocytosis). It is essential to provide information about the medication you are taking at that time.
Reporting side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information about the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Blister:
Store below 30°C.
Keep the blister in the original packaging to protect it from moisture.
Bottles of HDPE:
Store below 30°C.
Keep the bottle perfectly closed to protect it from moisture.
Medications should not be disposed of through drains or in the trash. Deposit the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Omeprazol STADA
-The active ingredient is omeprazole. Each capsule contains 20 mg of omeprazole
-The other components are: cornstarch and sucrose; sodium lauryl sulfate, disodium phosphate, mannitol, hypromellose, macrogol 6000, talc, poloxamer 80, titanium dioxide, methacrylic acid copolymer and ethyl acrylate copolymer. Capsule components: water, gelatin, quinoline yellow (E-104), titanium dioxide (E-171).
Appearance of the product and content of the packaging
Omeprazol STADA is presented in the form of hard gelatin capsules of yellow opaque color, containing white to cream-colored spherical microgranules.
The capsules are supplied in Al/Al blisters or HDPE bottles containing 14, 28 or 56 capsules.
Only some packaging sizes may be commercially available.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
STADA Laboratory, S.L.
Frederic Mompou, 5
08960 Sant Just Desvern
Barcelona - SPAIN
Responsible manufacturer
Liconsa, S.A.
Avda. Miralcampo, 7.
P.I. Miralcampo
19200 Azuqueca de Henares
Guadalajara - Spain
Last review date of this leaflet:February 2023
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.